XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.3
CAPITAL STOCK (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
SCHEDULE OF SHARE PURCHASE AGREEMENT

On April 28, 2024, the Company and the Purchaser entered into an Omnibus Amendment Agreement No. 1, which amended the SPA to, adjust the closings which were to take place under the SPA as follows:

 

SCHEDULE OF SHARE PURCHASE AGREEMENT

#  Initial Stated
Value of
Preferred
Stock to be
issued by
installment
   Warrants
to be issued
   Closing Date  Aggregate
Purchase
Price by
installment
(USD)
 
Initial Closing  $550,000    220,000   Initial Closing Date  $500,000 
Second Closing  $275,000        On or before June 30, 2024  $250,000 
Third Closing  $825,000    100,000   On or before June 30, 2024  $750,000 
Fourth Closing  $1,100,000        Such date as is no later than 180 days after the shares of Common Stock issuable in respect of the Series B Preferred Stock sold in each of the Initial Closing, Second Closing, the Third Closing, and the Fourth Closing have been registered under the Securities Act, subject to any limitations pursuant to Rule 415  $1,000,000.00 
Total  $2,750,000    320,000      $2,500,000 
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes common stock option activity:

SCHEDULE OF STOCK OPTION ACTIVITY 

   Options  

Weighted

Average

Exercise Price

 
Outstanding, December 31, 2022   83,333   $16.50 
Granted   93,333   $6.05 
Exercised   -    - 
Expired   -    - 
Expired / Forfeited   (33,333)   16.50 
Outstanding, December 31, 2023   176,666   $10.98 
Exercisable, December 31, 2023   120,833   $8.43 
Outstanding, December 31, 2023   176,666   $10.98 
           
           
Granted   13,333   $5.55 
Exercised   -    - 
Expired / Forfeited   (33,333)   16.50 
Outstanding, September 30, 2024   156,666   $9.34 
Exercisable, September 30, 2024   135,833   $8.25 
SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

The weighted average exercise prices, remaining lives for options granted, and exercisable as of September 30, 2024 were as follows:

SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE 

    Outstanding Options      Exercisable Options 

Options

Exercise

Price Per

Share

   Shares  

Life

(Years)

  

Weighted

Average

Exercise

Price

   Shares  

Weighted

Average

Exercise

Price

 
$16.50    60,000    3.87   $16.50    39,167   $16.50 
$4.80    83,333    4.25   $4.80    83,333   $4.80 
$5.55    13,333    2.78   $5.55    13,333   $5.55 
SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS

SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS 

Fair Value of Common Stock on measurement date  $14.854.35 
Risk free interest rate   4.10% - 3.30%
Volatility   232.05% - 92.54%
Dividend Yield   0%
Expected Term   6.0-3.0 

 

  (1) The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
  (2) The trading volatility was determined by calculating the volatility of the Company’s peer group.
  (3) The Company does not expect to pay a dividend in the foreseeable future
  (4) The Company, in accordance with staff accounting bulletin (“SAB”)14-D.2, used the simplified method (plain vanilla) to determine the overall expected term
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes common stock warrants activity:

SCHEDULE OF WARRANT ACTIVITY  

    Warrants    

Weighted

Average

Exercise Price

Per Share

 
Outstanding, December 31, 2022     133,333     $ 15.00  
Granted     24,500       22.14  
Exercised     (68,300 )     15.00  
Expired     -       -  
Cancelled     -       -  
Outstanding, December 31, 2023     89,533       16.95  
Exercisable, December 31, 2023     89,533       16.95  
Outstanding, December 31, 2023     89,533       16.95  
                 
Granted     322,800       5.80  
Exercised     -       -  
Expired     -       -  
Cancelled     -       -  
Outstanding, September 30, 2024     412,333       8.23  
Exercisable, September 30, 2024     412,333     $ 8.23  
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE

The weighted average exercise prices, remaining lives for warrants granted, and exercisable as of September 30, 2024, were as follows:

SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE 

   Outstanding and Vested Warrants
Weighted Average
Warrant
Exercise Price
Per Share
  Shares  Life (Years)
$8.23    12,333    4.06 
SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS

SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS

Fair Value of Common Stock on measurement date  $ 3.15 - $10.95
Risk-free interest rate    From 2.95% to 4.38%
Volatility    From 81.92% to 239.06%
Dividend Yield   0%
Expected Term   5 years 

 

  (1) The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
  (2) The trading volatility was determined by calculating the volatility of the Company’s peer group.
  (3) The Company does not expect to pay a dividend in the foreseeable future.